Showing results (361-370 of 6,352) with videos related to
Sort By:
Pageof 636
Immunology Letters|June 9, 2009
Possible contribution of DNase gamma to immunoglobulin V gene diversificationNoriaki Okamoto, Mariko Okamoto, Shinsuke Araki, et al.Immunology Letters|August 12, 2009
A promising new approach of VEGFR2-based DNA vaccine for tumor immunotherapyJinqi Yan, Rui Jia, Hongbin Song, et al.Immunology Letters|November 26, 2008
A broad-spectrum inhibitory peptide against staphylococcal enterotoxin superantigen SEA, SEB and SECSixiong Wang, Yafei Li, Hongyan Xiong, et al.Immunology Letters|October 8, 2009
Unraveling bacterial interactions with toll-like receptorsJos P M van Putten, Lieneke I Bouwman, Marcel R de ZoeteImmunology Letters|August 1, 1990
The role of CD4+ T cells in the protective immune response to Plasmodium chabaudi in vivoJ Langhorne, B Simon-Haarhaus, S J MedingImmunology Letters|August 1, 1990
Mutations with multiple independent origins in surface antigens mark the targets of biological selective pressureT F McCutchan, A P WatersImmunology Letters|June 16, 2009
Heterologous expressed toxic and non-toxic peptide variants of toxin CssII are capable to produce neutralizing antibodies against the venom of the scorpion Centruroides suffusus suffususKenya Hernández-Salgado, Georgina Estrada, Alejandro Olvera, et al.Immunology Letters|August 1, 2009
Expression of Th2-skewed pathology mediators in monocyte-derived type 2 of dendritic cells (DC2)Mitsumi Hata, Seiji Takahara, Hidetoshi Tsuzaki, et al.Immunology Letters|December 1, 1990
Calcium channel ligand binding to intact, concanavalin A and cyclic AMP-treated cells of the immune systemG V Pinchuk, L N Pinchuk, Y V Tkachenko, et al.Immunology Letters|May 12, 2009
Tumor agonist peptides break tolerance and elicit effective CTL responses in an inducible mouse model of hepatocellular carcinomaSimone Stahl, Torsten Sacher, Astrid Bechtold, et al.Pageof 636